Organization (Hospital)
Vienna Hospital Association
ClinicalTrials.gov lists Vienna Hospital Association as lead sponsor of 10 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 5 registered with a 2026 start date. The dashed outline is the pace from the 5 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Vienna Hospital Association: 10 lead-sponsored trials and 0 legal-entity registrations.
Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.
Disease areas (37)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Cataract | 9 |
| Pseudophakia | 3 |
| COVID-19 | 2 |
| Macular Degeneration | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
Showing 5 of 37 disease areas.
Trials by start year as sponsor or collaborator (5)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 5 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 1 |
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 0 of 3 hit target (n=3) | 1 of 3 on time (n=3) |
Journals published in (35)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| American journal of respiratory and critical care medicine | 3 |
| Journal of ophthalmology | 2 |
| The Journal of thoracic and cardiovascular surgery | 2 |
| The New England journal of medicine | 2 |
| Academic medicine : journal of the Association of American Medical Colleges | 1 |
Showing 5 of 35 journals.
Organization relationships (16)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Medical University of Vienna | Co sponsors trial with | 4 |
| Medical University of Graz | Co sponsors trial with | 4 |
| University of Zurich | Co sponsors trial with | 1 |
| Hospital Del Mar | Co sponsors trial with | 1 |
| Health New Zealand | Co sponsors trial with | 1 |
Showing 5 of 16 relationships.
Latest dated events (36)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-09-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-08-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-08-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-20 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-06 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 36 events.
Biomarker capability evidence (2)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| PHEX | Trial sponsor | Named in trial exclusion criteria |
| PHEX | Trial sponsor | Mentioned in trial text |
Biomarkers this organization publishes on (57)
Shown in this order: most publications first.
Showing 5 of 57 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, active development programs, approved assets, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.